Prova n\u00eb mb\u00ebshtetje t\u00eb Grupit t\u00eb P\u00ebrbashk\u00ebt t\u00eb Formularit (JFG) - P\u00ebrdorimet e Melatonin\u00ebs<\/h1>\n
Ekipi i Optimizimit t\u00eb Barnave n\u00eb NHS Bristol, North Somerset dhe South Gloucestershire ICB koordinon Grupin e P\u00ebrbashk\u00ebt t\u00eb Formularit (JFG). JFG p\u00ebrfshin p\u00ebrfaq\u00ebsues nga kujdesi par\u00ebsor dhe sekondar q\u00eb mbulojn\u00eb t\u00eb gjitha recetat n\u00eb t\u00eb gjith\u00eb Bristolin, North Somerset dhe South Gloucestershire.<\/p>\n
Formulari i P\u00ebrbashk\u00ebt p\u00ebrcakton k\u00ebrkesat p\u00ebr p\u00ebrshkrimin e ila\u00e7eve me kosto efektive n\u00eb vend. \u00c7do ila\u00e7 q\u00eb nuk \u00ebsht\u00eb i listuar n\u00eb Formular konsiderohet si Jo-Formular dhe nuk duhet t\u00eb p\u00ebrshkruhet rregullisht. Ju lutemi shihni Uebfaqja e Formularit t\u00eb P\u00ebrbashk\u00ebt t\u00eb Bristolit, Somersetit Verior dhe Gloucestershirit Jugor<\/a> p\u00ebr m\u00eb shum\u00eb informacion.<\/p>\n Ekipit t\u00eb Efektivitetit Klinik t\u00eb ICB iu k\u00ebrkua t\u00eb mb\u00ebshteste JFG-n\u00eb n\u00eb p\u00ebrgjigje t\u00eb aplikimeve t\u00eb b\u00ebra p\u00ebr tre indikacione t\u00eb ndryshme p\u00ebr melatonin\u00ebn. Aplikimet ishin p\u00ebr p\u00ebrdorim si m\u00eb posht\u00eb:<\/p>\n Ekipi i Efektivitetit Klinik (CE) i ICB nd\u00ebrmori tre shqyrtime t\u00eb provave, nj\u00eb p\u00ebr secilin prej p\u00ebrdorimeve t\u00eb propozuara t\u00eb melatonin\u00ebs t\u00eb listuara m\u00eb sip\u00ebr, p\u00ebr t\u00eb mb\u00ebshtetur vendimmarrjen e JFG-s\u00eb.<\/p>\n N\u00eb k\u00ebto shqyrtime t\u00eb provave, p\u00ebr aq sa ishte e mundur, u trajtuan pikat e m\u00ebposhtme p\u00ebr t\u00eb ndihmuar diskutimin n\u00eb JFG:<\/p>\n Rishikimi i provave tregoi nj\u00eb munges\u00eb t\u00eb provave k\u00ebrkimore me cil\u00ebsi t\u00eb mir\u00eb q\u00eb shqyrtojn\u00eb p\u00ebrdorimin e melatonin\u00ebs p\u00ebr rezultatet e gjumit n\u00eb demenc\u00eb. Provat e disponueshme u p\u00ebrqendruan kryesisht n\u00eb s\u00ebmundjen e Alzheimerit sesa n\u00eb llojet e tjera t\u00eb demenc\u00ebs.<\/p>\n Rezultati i diskutimit t\u00eb JFG-s\u00eb rreth k\u00ebtij p\u00ebrdorimi t\u00eb melatonin\u00ebs ishte se, bazuar n\u00eb munges\u00eb provash, ai nuk do t\u00eb ishte<\/em><\/strong> shtuar n\u00eb formular n\u00eb k\u00ebt\u00eb koh\u00eb. Megjithat\u00eb, duke pasur parasysh munges\u00ebn e studimeve q\u00eb shqyrtojn\u00eb k\u00ebt\u00eb indikacion, por provat e konsiderueshme anekdotike t\u00eb p\u00ebrfitimit, aty ku ishte p\u00ebrdorur 'jasht\u00eb formularit' n\u00eb Bristol, Somerset Verior dhe Gloucestershire Jugor, u porosit nj\u00eb studim lokal p\u00ebr t\u00eb zhvilluar nj\u00eb baz\u00eb provash p\u00ebr zon\u00ebn.<\/p>\n Rezultatet e k\u00ebtij studimi do t\u00eb ndihmojn\u00eb n\u00eb vendimmarrjen p\u00ebr aplikimet e ardhshme t\u00eb JFG p\u00ebr p\u00ebrdorimin e melatonin\u00ebs n\u00eb trajtimin e \u00e7rregullimeve t\u00eb gjumit tek pacient\u00ebt e rritur me demenc\u00eb.<\/p>\n Meqen\u00ebse nj\u00eb vendim u arrit dhe u miratua menj\u00ebher\u00eb pas takimit t\u00eb JFG-s\u00eb, ky shqyrtim i provave u konsiderua i p\u00ebrshtatsh\u00ebm p\u00ebr t'u ndar\u00eb n\u00eb Depozita e D\u00ebshmive WEAHSN<\/a>.<\/p>\n Rishikimi i provave tregoi nj\u00eb munges\u00eb t\u00eb dukshme provash mbi efektivitetin e p\u00ebrdorimit t\u00eb melatonin\u00ebs n\u00eb mjediset e PICU-s\u00eb dhe PHDU-s\u00eb. Megjithat\u00eb, kishte prova q\u00eb melatonina ka nj\u00eb profil t\u00eb mir\u00eb sigurie n\u00eb popullatat pediatrike dhe mund t\u00eb jet\u00eb e dobishme p\u00ebr rezultatet e gjumit tek f\u00ebmij\u00ebt n\u00eb nj\u00eb shkall\u00eb m\u00eb t\u00eb gjer\u00eb.<\/p>\n P\u00ebr m\u00eb tep\u00ebr, kishte prova se recetat \u2018jasht\u00eb formularit\u2019 p\u00ebr melatonin\u00ebn n\u00eb PICU\/PHDU po rriteshin n\u00eb nivel nd\u00ebrkomb\u00ebtar.<\/p>\n Rezultati i diskutimit JFG n\u00eb lidhje me k\u00ebt\u00eb p\u00ebrdorim t\u00eb melatonin\u00ebs ishte se duke pasur parasysh profilin e siguris\u00eb s\u00eb p\u00ebrdorimit t\u00eb melatonin\u00ebs tek pediatrit dhe koh\u00ebzgjatjen afatshkurt\u00ebr t\u00eb administrimit t\u00eb melatonin\u00ebs (dometh\u00ebn\u00eb, vet\u00ebm nd\u00ebrsa f\u00ebmija \u00ebsht\u00eb n\u00eb PICU\/PHDU), ai do t\u00eb ishte<\/em><\/strong> shtuar n\u00eb formular. Ekziston pritja q\u00eb p\u00ebrdorimi 'n\u00eb formular' do t\u00eb mund\u00ebsoj\u00eb nj\u00eb mbledhje m\u00eb t\u00eb mir\u00eb t\u00eb t\u00eb dh\u00ebnave lokale mbi p\u00ebrdorimin e melatonin\u00ebs p\u00ebr k\u00ebt\u00eb q\u00ebllim.<\/p>\n\n
Kontributi i Ekipit t\u00eb Efektivitetit Klinik<\/strong><\/h2>\n
\n
Ndikimi i 'Melatonin\u00ebs p\u00ebr rezultatet e gjumit n\u00eb demenc\u00eb'\u2018<\/strong><\/h2>\n
Ndikimi i 'Melatonin\u00ebs p\u00ebr rezultatet e gjumit n\u00eb PICU\/PHDU'\u2018<\/strong><\/h2>\n